These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle. Guo HC; Sun SQ; Jin Y; Yang SL; Wei YQ; Sun DH; Yin SH; Ma JW; Liu ZX; Guo JH; Luo JX; Yin H; Liu XT; Liu DX Vet Res; 2013 Jul; 44(1):48. PubMed ID: 23826638 [TBL] [Abstract][Full Text] [Related]
4. FMD empty capsids combined with the Immunostant Particle Adjuvant -ISPA or ISA206 induce protective immunity against foot and mouth disease virus. Bidart J; Mignaqui A; Kornuta C; Lupi G; Gammella M; Soria I; Galarza R; Ferella A; Cardillo S; Langellotti C; Quattrocchi V; Durocher Y; Wigdorovitz A; Marcipar I; Zamorano P Virus Res; 2021 May; 297():198339. PubMed ID: 33596405 [TBL] [Abstract][Full Text] [Related]
5. A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals. Uddowla S; Hollister J; Pacheco JM; Rodriguez LL; Rieder E J Virol; 2012 Nov; 86(21):11675-85. PubMed ID: 22915802 [TBL] [Abstract][Full Text] [Related]
6. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals. Grubman MJ Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996 [TBL] [Abstract][Full Text] [Related]
7. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses. Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle. Steigerwald R; Brake DA; Barrera J; Schutta CJ; Kalla M; Wennier ST; Volkmann A; Hurtle W; Clark BA; Zurita M; Pisano M; Kamicker BJ; Puckette MC; Rasmussen MV; Neilan JG Vaccine; 2020 Jan; 38(4):769-778. PubMed ID: 31718901 [TBL] [Abstract][Full Text] [Related]
9. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine. Barrera J; Brake DA; Schutta C; Ettyreddy D; Kamicker BJ; Rasmussen MV; Bravo de Rueda C; Zurita M; Pisano M; Hurtle W; Brough DE; Butman BT; Harper BG; Neilan JG Vaccine; 2018 Nov; 36(48):7345-7352. PubMed ID: 30327212 [TBL] [Abstract][Full Text] [Related]
11. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles. Gullberg M; Lohse L; Bøtner A; McInerney GM; Burman A; Jackson T; Polacek C; Belsham GJ PLoS One; 2016; 11(6):e0157435. PubMed ID: 27294397 [TBL] [Abstract][Full Text] [Related]
12. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers. Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951 [TBL] [Abstract][Full Text] [Related]
14. Application of the thermofluor PaSTRy technique for improving foot-and-mouth disease virus vaccine formulation. Kotecha A; Zhang F; Juleff N; Jackson T; Perez E; Stuart D; Fry E; Charleston B; Seago J J Gen Virol; 2016 Jul; 97(7):1557-1565. PubMed ID: 27002540 [TBL] [Abstract][Full Text] [Related]
15. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle. Sreenivasa BP; Mohapatra JK; Pauszek SJ; Koster M; Dhanya VC; Tamil Selvan RP; Hosamani M; Saravanan P; Basagoudanavar SH; de Los Santos T; Venkataramanan R; Rodriguez LL; Grubman MJ Vet Microbiol; 2017 May; 203():196-201. PubMed ID: 28619144 [TBL] [Abstract][Full Text] [Related]
16. The pH stability of foot-and-mouth disease virus. Yuan H; Li P; Ma X; Lu Z; Sun P; Bai X; Zhang J; Bao H; Cao Y; Li D; Fu Y; Chen Y; Bai Q; Zhang J; Liu Z Virol J; 2017 Nov; 14(1):233. PubMed ID: 29183342 [TBL] [Abstract][Full Text] [Related]
17. Novel Foot-and-Mouth Disease Vaccine Platform: Formulations for Safe and DIVA-Compatible FMD Vaccines With Improved Potency. Hardham JM; Krug P; Pacheco JM; Thompson J; Dominowski P; Moulin V; Gay CG; Rodriguez LL; Rieder E Front Vet Sci; 2020; 7():554305. PubMed ID: 33088833 [TBL] [Abstract][Full Text] [Related]
18. Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle. Xiao Y; Chen HY; Wang Y; Yin B; Lv C; Mo X; Yan H; Xuan Y; Huang Y; Pang W; Li X; Yuan YA; Tian K BMC Biotechnol; 2016 Jul; 16(1):56. PubMed ID: 27371162 [TBL] [Abstract][Full Text] [Related]